The Carlyle Group Inc. 13D and 13G filings for Phathom Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-12 4:36 pm Purchase |
2023-12-31 | 13G | Phathom Pharmaceuticals, Inc. PHAT |
Carlyle Group Inc. CG |
3,496,808 6.100% |
561,702 (+19.14%) |
Filing |
| 2023-03-09 4:17 pm Purchase |
2023-03-01 | 13G | Phathom Pharmaceuticals, Inc. PHAT |
Carlyle Group Inc. CG |
2,935,106 6.700% |
2,935,106 (New Position) |
Filing |